Home > Press > Microfluidics develops methods for processing carbon nanotubes
Abstract:
Microfluidics, a wholly owned subsidiary of MFIC Corporation, announces methods for processing bulk carbon nanotubes. Microfluidics has devised a methodology to process, deagglomerate, purify and stabilize these processed nanotubes so they can be used in an optimal manner, thus achieving enhanced functionality and performance.
The company has identified and demonstrated numerous operational protocols utilizing its Microfluidizer® processor systems to prepare these bulk nanotubes for their ultimate specific uses. These applications capitalize on the unique mechanical, electrical and thermal properties of carbon nanotubes, and require dispersion of the nanotubes in liquid media and independent length reduction of the carbon nanotubes.
Carbon nanotubes are noted for their tubular shape, extremely small diameter with respect to length, and exceptional physical, mechanical and electrical properties. When prepared in diameters in the 10-50 nanometer range, the unique characteristics of strength, conductivity and quantum behavior become highly desirable and are thus incorporated into a multitude of commercial products.
Microfluidizer® processors are ideal for conditioning carbon nanotubes (and nanomaterials in general) for applications that include high tensile strength polymers, fabric treatments, lubricants, medical therapeutics, computer memory and chips, electronic devices, medical diagnostic biolabels, and photovoltaic cell components.
####
About Microfluidics
Microfluidics, a wholly owned subsidiary of MFIC Corporation, is a supplier of advanced fluid processing equipment and reaction technology for laboratory, pilot scale and manufacturing applications. The equipment enables the manufacture and formulation of numerous nanomaterials and nanoscale products and produces the most uniform and smallest liquid and suspended solid particles available.
Microfluidics has been a worldwide supplier of Microfluidizer® high shear fluid processing systems to the biotechnology, pharmaceutical, chemical, cosmetics/personal care and food industries since 1984. As leader in the field, Microfluidics has enabled numerous companies and institutions to formulate, validate and produce licensed drugs for the worldwide healthcare market.
Companies seeking to produce difficult-to-formulate products or to find better methods of bio-processing can take advantage of complimentary sample testing at one of three Microfluidics facilities. Visit www.microfluidicscorp.com, email: or contact Microfluidics at 800.370.5452 for application information.
For more information, please click here
Contacts:
Dinah Alobeid
Account Representative
Gray & Rice Public Relations
One Washington Mall
Boston, MA 02108
(ph) (617) 367-0100 ext. 127
(fax) (617) 367-0160
www.grayandrice.com
Copyright © Microfluidics
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Microfluidics/Nanofluidics
Implantable device shrinks pancreatic tumors: Taming pancreatic cancer with intratumoral immunotherapy April 14th, 2023
Researchers design new inks for 3D-printable wearable bioelectronics: Potential uses include printing electronic tattoos for medical tracking applications August 19th, 2022
Oregon State University research pushes closer to new therapy for pancreatic cancer May 6th, 2022
Nanotubes/Buckyballs/Fullerenes/Nanorods/Nanostrings
Tests find no free-standing nanotubes released from tire tread wear September 8th, 2023
Detection of bacteria and viruses with fluorescent nanotubes July 21st, 2023
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||